1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
SpectraScience, Inc.

SpectraScience, Inc.

SCIE
SpectraScience, Inc.US flagOther OTC
0.00
USD
- -
- -
4,924.00Market Cap
SpectraScience, Inc.
SCIE
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

1999
2000
2001
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
-0.01
-0.02
-0.03
-0.1
-0.08
-0.1
-0.07
-0.04
-0.08
-0.02
-0.03
-0.02
-0.01
- -
Basic EPS, GAAP
- -
- -
- -
-0.01
-0.02
-0.02
-0.04
-0.06
-0.04
-0.03
-0.03
-0.02
-0.01
-0.01
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
-0.02
-0.06
-0.14
-0.17
-0.26
-0.26
-0.26
-0.31
-0.25
-0.26
-0.21
-0.06
-0.01
Book Value per Share
- -
- -
- -
0.04
0.02
0.01
0.17
0.05
0.07
0.04
- -
-0.03
-0.03
-0.03
-0.04
-0.02
-0.01
Tangible Book Value per Share
- -
- -
- -
32
38
38
42
66
70
92
108
119
160
170
216
698
1,836
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
-8,704.31
-2,654.82
-18,848.74
-17,832.77
-936.66
-1,138.21
- -
-37,626.88
-47,459.92
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
Depreciation Expense
-2
-2
-3
- -
-1
-1
-3
-5
-4
-4
-5
-9
-3
-4
-4
-4
-5
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
-8,495.54
-2,652.05
-17,330.33
-17,812.27
-1,971.1
-1,145.69
- -
-55,073.76
-86,729.46
- -
Profit Margin (%)
4
4
1
1
1
- -
6
2
4
4
- -
-3
-4
-6
-8
-10
-12
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
LT Debt
4
4
1
2
1
1
10
7
8
7
3
-2
-3
-4
-7
-11
-13
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'17
Jun'17
Sep'17
ST Debt
6
6
7
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,413
1,963
4,824
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'17
Jun'17
Sep'17
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
11
12
13
Payables & Accruals
4
4
5
ST Debt
6
6
7
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
187.45%
16.24%
50.24%
Free Cash Flow
21.1%
-10.62%
-19.95%
Net Income, GAAP
28.3%
17.66%
22.88%
Sales/Revenue/Turnover
- -
- -
-21.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
-0.01
- -
- -
- -
-0.02
2016
- -
- -
- -
- -
-0.01
2017
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -
Similar Companies
Revenio Group Oyj (REG1V.HE)
Kontour (Xi'an) Medical Technology Co., Ltd. Class A (688314.SS)
Japan Eyewear Holdings Co., Ltd. (5889.T)
Nanalysis Scientific Corp. (NSCIF)
Zhende Medical Co., Ltd. (603301.SS)
Goodbody Health Limited (GDBYF)
Business
SpectraScience Inc (SCIE) develops and markets non-invasive optical biopsy systems for real-time tissue analysis to detect normal, pre-cancerous or cancerous conditions during endoscopic procedures in the United States, Europe and internationally. The company offers the WavSTAT3 optical biopsy system for colon tissue diagnosis without physical biopsy removal; WavSTAT4 optical biopsy system, which uses UV laser light for instant colon cancer screening; mobile consoles; disposable forceps; and develops esophageal diagnosis applications for pre-cancerous and cancerous tissue detection across various body sites. Founded in 1983 and headquartered at 11568 Sorrento Valley Road, San Diego, California, the company, formerly GV Medical Inc until its name change in October 1992, operates in the medical devices segment of healthcare with approximately seven employees. No major recent partnerships, funding rounds, acquisitions, product launches or strategic shifts reported in the last one to two years; the firm remains delinquent in SEC periodic filings since at least June 2023.

Company News

APIChatGPT

  • newsfilecorp.com

    SEC Suspends Trading in Inactive Issuer Touted on Social Media

  • pulse2.com

    SCIE Stock Price Spikes This Past Week: Why It Happened